DV
Dividend Vision

MBX — MBX Biosciences, Inc.

MBX Biosciences, Inc. (MBX)

Total return is 328.6% over the past 1.9 years, 286.5 points ahead of SPY at 42.1%. Its deepest 1-year drawdown was 37.6%.

MBX Biosciences, Inc. is an equity fund that focuses on the biosciences sector, having launched in September 2024. As a stock fund with no current distribution frequency or yield profile, it is oriented toward capital appreciation rather than income generation. This fund may appeal to investors seeking growth exposure in the biosciences industry, though limited historical data is available given its recent inception.

MBX key facts

Asset type
Stock
Asset class
Equity
Inception date
09/12/2024
Distribution frequency
None
Last close
$68.57
Market cap
$3,302,337,792
Average volume
503100.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.37